Copper drug clears toxic Alzheimer’s proteins and restores memory
Researchers at Monash University have discovered that a copper-based drug, Cu(ATSM), can repair the blood-brain barrier and clear toxic amyloid-beta proteins in Alzheimer's models. The treatment significantly improved spatial memory and cognitive function in laboratory studies.
Why it matters
This breakthrough offers a potential new therapeutic pathway for treating Alzheimer's by targeting neurovascular dysfunction rather than just protein accumulation.
Researchers at Monash University have identified a promising new approach to tackling Alzheimer's disease. In laboratory studies, they found that a copper-based drug not only reduced the buildup of toxic proteins linked to the disease but also improved long-term spatial memory.
The article reports on scientific findings from a peer-reviewed journal without political or social commentary.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in